Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nihon Kohden Corporation (6849:JPX), powered by AI.
Nihon Kohden Corporation is currently trading at ¥1,337.5. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nihon Kohden Corporation on Alpha Lenz.
Nihon Kohden Corporation's P/E ratio is 15.8.
“Nihon Kohden Corporation trades at a P/E of 15.8 (fair value) with modest ROE of 7.8%.”
Ask for details →Nihon Kohden Corporation is a prominent manufacturer and supplier in the medical electronics industry. Its primary focus is on developing innovative healthcare solutions such as measuring instruments for clinical examination, patient monitors, and electrocardiographs (ECGs). These devices play a crucial role in hospitals and medical facilities, aiding in accurate diagnosis and patient care management. Additionally, the company is well-known for its neurological diagnostic equipment, emphasizing its commitment to enhancing neurological medical sciences. With a global presence, Nihon Kohden serves various sectors, including hospitals, medical research institutions, and specialized healthcare centers, ensuring comprehensive healthcare support worldwide. Established in 1951 and based in Japan, the corporation is recognized for its cutting-edge technology and contribution to the advancement of medical diagnostics, becoming an integral player in the medical technology market.
“Nihon Kohden Corporation trades at a P/E of 15.8 (fair value) with modest ROE of 7.8%.”
Ask for details →Nihon Kohden Corporation (ticker: 6849) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 6,114 employees. Market cap is $222.1B.
The current price is 1,337.5 with a P/E ratio of 15.76x and P/B of 1.24x.
ROE is 7.82% and operating margin is 9.19%. Annual revenue is $225.4B.